Metabolix Cmn Stk (MBLX) 0.41 $MBLX Metabolix A
Post# of 273257
Posted On: 09/03/2016 3:10:08 AM
Metabolix Cmn Stk (MBLX) 0.41 $MBLX
Metabolix Announces $10 Million Binding Letter of Intent for Sale of Biopolymer Assets to CJ CheilJedang
GlobeNewswire - Mon Aug 22, 3:05PM CDT
Metabolix, Inc. (NASDAQ:MBLX) announced today that it has entered into a binding letter of intent ("LOI"
with CJ CheilJedang Corporation ("CJ" for the sale of its biopolymer intellectual property and certain laboratory equipment for a total purchase price of $10 million. The first $2 million of the purchase price was paid by CJ on execution of the LOI and the remaining balance is payable on closing of the transaction, which is anticipated in mid-September. Completion of the transaction is subject to the negotiation of definitive agreements and other customary conditions.
MBLX: 0.41 (+0.01)
Global Bioplastic Market Research Report 2015-2022 - Leading Companies are Arkema Group, Novamont S.p.A., Metabolix Inc., DSM & Braskem - Research and Markets
BusinessWire - Wed Aug 03, 7:48AM CDT
Research and Markets has announced the addition of the "Global Bioplastic Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2015-2022" report to their offering.
MBLX: 0.41 (+0.01)
Metabolix Raises $2 Million in Amendment to Licensing Deal with Tepha
GlobeNewswire - Wed May 18, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX) announced today that it has entered into an amendment to its license agreement with Tepha, Inc., a Lexington, Massachusetts based medical device company that licenses Metabolix PHA biopolymer technology for use in certain medical applications. The amendment calls for a $2.0 million lump sum payment to Metabolix. In exchange, Metabolix agreed to forgo future royalties under its existing license agreement with Tepha and to provide two additional Metabolix production strains and related intellectual property to Tepha for use in the production of Tepha's medical devices.
MBLX: 0.41 (+0.01)
Metabolix Evaluating Strategic Alternatives for its Specialty PHA Biopolymers Business and Yield10 Bioscience Program
GlobeNewswire - Mon May 16, 3:30PM CDT
Metabolix, Inc. (NASDAQ:MBLX) announced today that the Company is exploring strategic alternatives for its specialty biopolymers business and for its Yield10 crop science program. The Company cited outside strategic interest in its biopolymers business as well as a challenging financing environment as key considerations leading to this development.
MBLX: 0.41 (+0.01)
Metabolix to Highlight Mirel PHA Biopolymers in Packaging Applications at SustPack 2016
GlobeNewswire - Thu Apr 07, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today it will highlight a range of packaging applications for its Mirel PHA biopolymers at SustPack 2016. Show attendees may visit Metabolix at Booth 27 during SustPack 2016, to be held in Chicago, Illinois on Monday, April 11 through Wednesday, April 13, 2016.
MBLX: 0.41 (+0.01)
Metabolix Announces Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Tue Mar 29, 3:07PM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported financial results for the three months and full year ended December 31, 2015.
MBLX: 0.41 (+0.01)
Metabolix Signs MOU with CJ CheilJedang for Strategic Commercial Manufacturing Arrangement
GlobeNewswire - Tue Mar 29, 3:05PM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it has entered into a Memorandum of Understanding ("MOU" with CJ CheilJedang Corporation ("CJ" for a strategic commercial manufacturing arrangement for specialty PHAs, including the Company's newly launched amorphous PHA ("a-PHA" . Under the non-binding MOU, the companies have agreed to work together toward the successful conclusion of definitive agreements under which CJ will fund, construct and operate a 10 kilo tonne PHA production unit at CJ's Fort Dodge, Iowa facility based on Metabolix's PHA technology. Under the contemplated definitive agreements, Metabolix will buy the specialty PHAs produced at the Fort Dodge facility from CJ, and market and sell the materials to its commercial customers. The companies also expect to define a framework for longer term expansion of the collaboration for larger scale PHA production and related commercial activities.
MBLX: 0.41 (+0.01)
Metabolix to Provide Company Update at Source Capital Conference
GlobeNewswire - Wed Feb 10, 8:05AM CST
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, will review 2015 highlights and discuss its outlook for 2016 in a presentation scheduled for 4:00 p.m. E.T. today at the Source Capital Disruptive Growth and Healthcare Conference.
MBLX: 0.41 (+0.01)
Metabolix to Present at Source Capital Conference
GlobeNewswire - Thu Feb 04, 3:09PM CST
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that management will review 2015 highlights and discuss its outlook for 2016 in a presentation to investors at the Source Capital 2016 Disruptive Growth and Healthcare Conference in New York City on Wednesday, February 10, 2016 from 4:00 - 4:25 p.m. EST.
MBLX: 0.41 (+0.01)
Metabolix to Relocate Corporate Headquarters to Woburn, Massachusetts in 2016
GlobeNewswire - Tue Jan 26, 3:09PM CST
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it has signed a 10.5 year lease agreement for 30,000 square feet of state-of-the-art laboratory and office space at 19 Presidential Way in Woburn, Massachusetts. Metabolix expects to take occupancy of the space as its corporate headquarters in June 2016 as it exits space in Cambridge, Massachusetts.
MBLX: 0.41 (+0.01)
World Bioplastics Market - Opportunities and Forecast, 2014 - 2020 - Projected to Reach $30.8 Billion
M2 - Mon Dec 21, 10:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/q923tn/world_bioplastics) has announced the addition of the "World Bioplastics Market - Opportunities and Forecast, 2014 - 2020" report to their offering. In 2014, the market for bio-plastics stood at 4,869.2 kilo tons and is expected to grow at a CAGR of 17.5% during 2015-2020. Increasing adoption of biodegradable products and increasing popularity in the end user industries are the key factors driving the growth of bio-plastics market. However, its high production cost may hamper the market growth to a certain extent. Geographically, the market has been segmented into North America, Europe, and Asia Pacific & LAMEA. In 2014, Europe was highest revenue generating segment. European policy-makers support to the European bioplastics manufactures and increasing adoption in the Germany, Italy and United Kingdom are the key factors responsible for the growth of bioplastics market in Europe. However, Asia Pacific will be the fastest growing market and is expected to grow at a CAGR of 19.6% during 2015-2020 attributable to the lions share investments made by the global giants in the region due to availability of huge renewable feedstock. According to a new report, the global market for bioplastics would reach $30.8 billion by 2020, registering a CAGR of 14.8% during 2015-2020. The rising environmental awareness among the consumers and substantial curiosity of packaging industries towards biodegradability are the key factors responsible for the increasing adoption of bioplastics in rigid packaging applications. The rigid plastic application would account for more than 40% of the market revenue by 2020. Key findings of the study: - Rigid plastics would be the fastest growing application segment, at a CAGR of 31.8%, during the forecast period - Bio-PET 30 segment is expected to have healthy volume growth, at 25.7% CAGR, during the forecast period. - Polyesters and starch blends segment collectively accounted for about one-third of the overall biodegradable bioplastic market in 2014. - PLA is projected to be the fastest growing segment in the overall biodegradable plastics market, in terms of revenue and volume. Key Topics Covered: CHAPTER 1: INTRODUCTION CHAPTER 2: EXECUTIVE SUMMARY CHAPTER 3: MARKET OVERVIEW CHAPTER 4: WORLD BIOPLASTIC MARKET, BY TYPE CHAPTER 5: WORLD BIOPLASTIC MARKET, BY APPLICATION CHAPTER 6: WORLD BIOPLASTIC MARKET, BY GEOGRAPHY CHAPTER 7: COMPANY PROFILE Companies Mentioned: - BASF SE - Biome Technologies Plc - Braskem - Cardia Bioplastics - Corbion Purac - FKuR Kunststoff GmbH - Innovia Films - Metabolix, Inc. - NOVAMONT SPA - Natureworks LLC For more information visit http://www.researchandmarkets.com/research/q9...ioplastics
MBLX: 0.41 (+0.01)
What's Driving the Price Movement - Research on HMN Financial, Metabolix, Brainstorm Cell Therapeutics and Milestone Scientific
ACCESSWIRE - Fri Dec 04, 7:30AM CST
NEW YORK, NY / ACCESSWIRE / December 4, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: HMN Financial Inc. (NASDAQ: HMNF), Metabolix Inc. (NASDAQ: MBLX), Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) and Milestone Scientific Inc. (NYSE: MLSS). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
HMNF: 14.79 (+0.43), MLSS: 2.18 (-0.17), BCLI: 2.39 (-0.04), MBLX: 0.41 (+0.01)
Metabolix Announces Third Quarter 2015 Financial Results
GlobeNewswire - Tue Nov 10, 3:05PM CST
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported financial results for the three months ended September 30, 2015.
MBLX: 0.41 (+0.01)
Renewable Chemicals Market 2015 - Alcohols, Biopolymers, Platform Chemicals & Others - Global Trends & Forecast to 2020
M2 - Tue Nov 10, 4:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/x84prd/renewable) has announced the addition of the "Renewable Chemicals Market - Alcohols (Ethanol, Methanol), Biopolymers (Starch Blends, Regenerated Cellulose, PBS, Bio-PET, PLA, PHA, Bio-PE, and Others), Platform Chemicals & Others - Global Trends & Forecast to 2020" report to their offering. The global renewable chemicals market is estimated to be USD 49.0 Billion in 2015 and is projected to reach USD 84.3 Billion by 2020, at a CAGR of 11.47% between 2015 and 2020. The renewable chemicals market is currently facing considerable competition from conventional chemicals derived from petrochemical feedstock; because the renewable chemicals market is susceptible to the volatility in crude oil prices, rising environmental concerns and governmental litigations. Market participants are witnessing the need to make a paradigm shift from petrochemical feedstock to renewable feedstock. This move would not only bring in economic benefits, it would also successfully address the rising concern over greenhouse gas emissions and their lasting impact on the environment. The threat of substitutes for renewable chemicals market is high. Presently, renewable chemicals account for a small share of the overall chemicals market. These renewable chemicals have higher prices when compared to the conventional chemicals. This ensures large availability of alternative chemicals for buyers and increases the chances of substitution. There are issues regarding the performance of some renewable chemicals which restricts its penetration in application markets. The increase in capacity utilization rate and new products launch are estimated to make the renewable chemicals market more competitive. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Renewable Chemicals Market, By Product Type 8 Renewable Chemicals Market, By Application 9 Regional Analysis 10 Catalysis & Technologies 11 Competitive Landscape 12 Company Profiles - BASF SE - Bioamber Inc. - Biome Technologies Plc - Biomethanol Chemie Nederland B.V. - Braskem - Cobalt Technologies Inc. - Corbion NV (Purac) - Dupont Tate & Lyle Bio Products Company, LLC - Genomatica Inc. - Metabolix Inc. - Mitsubishi Chemical Corp. - Myriant Corporation - Natureworks Llc - Reverdia For more information visit http://www.researchandmarkets.com/research/x84prd/renewable
MBLX: 0.41 (+0.01)
Metabolix to Present at Drexel Hamilton Conference
GlobeNewswire - Fri Oct 30, 8:15AM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that management will make a presentation to investors at the Drexel Hamilton Micro Cap Investor Forum on Thursday, November 12, 2015 at 9:00 a.m. ET.
MBLX: 0.41 (+0.01)
Metabolix to Conduct Webcast of Its Third Quarter 2015 Earnings Call
GlobeNewswire - Tue Oct 27, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it will be releasing its third quarter 2015 financial results after the market close on Tuesday, November 10, 2015. The full text of the earnings release also will be available on the Company's website at www.metabolix.com.
MBLX: 0.41 (+0.01)
Metabolix Signs Global, Exclusive Distribution Agreement With Kolar Filtration
GlobeNewswire - Thu Oct 15, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX) announced today that it has signed a global, exclusive distribution agreement with Kolar Filtration LLC for PHA-based denitrification pellets in water treatment applications including ornamental and hobby aquaria, ornamental ponds and fresh/salt water hatcheries and aqua farming. Under the agreement, Kolar will promote and market PHA-based denitrification pellets and will assume responsibility for servicing Metabolix's current roster of customers for DP9002 denitrification pellets.
MBLX: 0.41 (+0.01)
Metabolix, Inc. Announces $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
GlobeNewswire - Wed Oct 07, 3:05PM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced that it has entered into a $20 million common stock purchase agreement with Aspire Capital Fund, LLC. Under terms of the agreement, Aspire has committed to purchase up to $20 million of Metabolix's common stock over a 30 month period beginning on the effective date of the registration statement relating to the transaction. Common stock may be sold from time to time at the company's option under a pricing formula based on prevailing market prices around the time of each sale.
MBLX: 0.41 (+0.01)
Metabolix to Present New Findings on Multifunctional Benefits of PHA Biopolymers in PVC Applications
GlobeNewswire - Tue Oct 06, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced that it will present its latest findings on the multifunctional benefits of bio-based PHA copolymers in a range of applications for polyvinyl chloride (PVC) and wood polymer composites. The new findings will be a key part of a technical presentation, entitled "Bio-based PHA Copolymers as Multifunctional Additives for Poly Vinyl Chloride Compound," to be delivered by Mansoor Akhthar, Metabolix application development manager - PVC, at the upcoming Vinyltec 2015 conference Oct.13-15 in Akron, Ohio.
MBLX: 0.41 (+0.01)
CORRECTING and REPLACING -- Metabolix Launches Yield10 Bioscience to Develop and Commercialize Innovations in Crop Science
GlobeNewswire - Thu Sep 17, 9:03AM CDT
In a release issued under the same headline earlier today by Metabolix, Inc. (NASDAQ:MBLX) please note that the link in the tenth paragraph of the release, should be "http://ir.metabolix.com/events.cfm" not "www.metabolix.com/events" as previously stated.
MBLX: 0.41 (+0.01)
Metabolix Announces $10 Million Binding Letter of Intent for Sale of Biopolymer Assets to CJ CheilJedang
GlobeNewswire - Mon Aug 22, 3:05PM CDT
Metabolix, Inc. (NASDAQ:MBLX) announced today that it has entered into a binding letter of intent ("LOI"
with CJ CheilJedang Corporation ("CJ" for the sale of its biopolymer intellectual property and certain laboratory equipment for a total purchase price of $10 million. The first $2 million of the purchase price was paid by CJ on execution of the LOI and the remaining balance is payable on closing of the transaction, which is anticipated in mid-September. Completion of the transaction is subject to the negotiation of definitive agreements and other customary conditions. MBLX: 0.41 (+0.01)
Global Bioplastic Market Research Report 2015-2022 - Leading Companies are Arkema Group, Novamont S.p.A., Metabolix Inc., DSM & Braskem - Research and Markets
BusinessWire - Wed Aug 03, 7:48AM CDT
Research and Markets has announced the addition of the "Global Bioplastic Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2015-2022" report to their offering.
MBLX: 0.41 (+0.01)
Metabolix Raises $2 Million in Amendment to Licensing Deal with Tepha
GlobeNewswire - Wed May 18, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX) announced today that it has entered into an amendment to its license agreement with Tepha, Inc., a Lexington, Massachusetts based medical device company that licenses Metabolix PHA biopolymer technology for use in certain medical applications. The amendment calls for a $2.0 million lump sum payment to Metabolix. In exchange, Metabolix agreed to forgo future royalties under its existing license agreement with Tepha and to provide two additional Metabolix production strains and related intellectual property to Tepha for use in the production of Tepha's medical devices.
MBLX: 0.41 (+0.01)
Metabolix Evaluating Strategic Alternatives for its Specialty PHA Biopolymers Business and Yield10 Bioscience Program
GlobeNewswire - Mon May 16, 3:30PM CDT
Metabolix, Inc. (NASDAQ:MBLX) announced today that the Company is exploring strategic alternatives for its specialty biopolymers business and for its Yield10 crop science program. The Company cited outside strategic interest in its biopolymers business as well as a challenging financing environment as key considerations leading to this development.
MBLX: 0.41 (+0.01)
Metabolix to Highlight Mirel PHA Biopolymers in Packaging Applications at SustPack 2016
GlobeNewswire - Thu Apr 07, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today it will highlight a range of packaging applications for its Mirel PHA biopolymers at SustPack 2016. Show attendees may visit Metabolix at Booth 27 during SustPack 2016, to be held in Chicago, Illinois on Monday, April 11 through Wednesday, April 13, 2016.
MBLX: 0.41 (+0.01)
Metabolix Announces Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Tue Mar 29, 3:07PM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported financial results for the three months and full year ended December 31, 2015.
MBLX: 0.41 (+0.01)
Metabolix Signs MOU with CJ CheilJedang for Strategic Commercial Manufacturing Arrangement
GlobeNewswire - Tue Mar 29, 3:05PM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it has entered into a Memorandum of Understanding ("MOU"
with CJ CheilJedang Corporation ("CJ" for a strategic commercial manufacturing arrangement for specialty PHAs, including the Company's newly launched amorphous PHA ("a-PHA" . Under the non-binding MOU, the companies have agreed to work together toward the successful conclusion of definitive agreements under which CJ will fund, construct and operate a 10 kilo tonne PHA production unit at CJ's Fort Dodge, Iowa facility based on Metabolix's PHA technology. Under the contemplated definitive agreements, Metabolix will buy the specialty PHAs produced at the Fort Dodge facility from CJ, and market and sell the materials to its commercial customers. The companies also expect to define a framework for longer term expansion of the collaboration for larger scale PHA production and related commercial activities. MBLX: 0.41 (+0.01)
Metabolix to Provide Company Update at Source Capital Conference
GlobeNewswire - Wed Feb 10, 8:05AM CST
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, will review 2015 highlights and discuss its outlook for 2016 in a presentation scheduled for 4:00 p.m. E.T. today at the Source Capital Disruptive Growth and Healthcare Conference.
MBLX: 0.41 (+0.01)
Metabolix to Present at Source Capital Conference
GlobeNewswire - Thu Feb 04, 3:09PM CST
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that management will review 2015 highlights and discuss its outlook for 2016 in a presentation to investors at the Source Capital 2016 Disruptive Growth and Healthcare Conference in New York City on Wednesday, February 10, 2016 from 4:00 - 4:25 p.m. EST.
MBLX: 0.41 (+0.01)
Metabolix to Relocate Corporate Headquarters to Woburn, Massachusetts in 2016
GlobeNewswire - Tue Jan 26, 3:09PM CST
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it has signed a 10.5 year lease agreement for 30,000 square feet of state-of-the-art laboratory and office space at 19 Presidential Way in Woburn, Massachusetts. Metabolix expects to take occupancy of the space as its corporate headquarters in June 2016 as it exits space in Cambridge, Massachusetts.
MBLX: 0.41 (+0.01)
World Bioplastics Market - Opportunities and Forecast, 2014 - 2020 - Projected to Reach $30.8 Billion
M2 - Mon Dec 21, 10:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/q923tn/world_bioplastics) has announced the addition of the "World Bioplastics Market - Opportunities and Forecast, 2014 - 2020" report to their offering. In 2014, the market for bio-plastics stood at 4,869.2 kilo tons and is expected to grow at a CAGR of 17.5% during 2015-2020. Increasing adoption of biodegradable products and increasing popularity in the end user industries are the key factors driving the growth of bio-plastics market. However, its high production cost may hamper the market growth to a certain extent. Geographically, the market has been segmented into North America, Europe, and Asia Pacific & LAMEA. In 2014, Europe was highest revenue generating segment. European policy-makers support to the European bioplastics manufactures and increasing adoption in the Germany, Italy and United Kingdom are the key factors responsible for the growth of bioplastics market in Europe. However, Asia Pacific will be the fastest growing market and is expected to grow at a CAGR of 19.6% during 2015-2020 attributable to the lions share investments made by the global giants in the region due to availability of huge renewable feedstock. According to a new report, the global market for bioplastics would reach $30.8 billion by 2020, registering a CAGR of 14.8% during 2015-2020. The rising environmental awareness among the consumers and substantial curiosity of packaging industries towards biodegradability are the key factors responsible for the increasing adoption of bioplastics in rigid packaging applications. The rigid plastic application would account for more than 40% of the market revenue by 2020. Key findings of the study: - Rigid plastics would be the fastest growing application segment, at a CAGR of 31.8%, during the forecast period - Bio-PET 30 segment is expected to have healthy volume growth, at 25.7% CAGR, during the forecast period. - Polyesters and starch blends segment collectively accounted for about one-third of the overall biodegradable bioplastic market in 2014. - PLA is projected to be the fastest growing segment in the overall biodegradable plastics market, in terms of revenue and volume. Key Topics Covered: CHAPTER 1: INTRODUCTION CHAPTER 2: EXECUTIVE SUMMARY CHAPTER 3: MARKET OVERVIEW CHAPTER 4: WORLD BIOPLASTIC MARKET, BY TYPE CHAPTER 5: WORLD BIOPLASTIC MARKET, BY APPLICATION CHAPTER 6: WORLD BIOPLASTIC MARKET, BY GEOGRAPHY CHAPTER 7: COMPANY PROFILE Companies Mentioned: - BASF SE - Biome Technologies Plc - Braskem - Cardia Bioplastics - Corbion Purac - FKuR Kunststoff GmbH - Innovia Films - Metabolix, Inc. - NOVAMONT SPA - Natureworks LLC For more information visit http://www.researchandmarkets.com/research/q9...ioplastics
MBLX: 0.41 (+0.01)
What's Driving the Price Movement - Research on HMN Financial, Metabolix, Brainstorm Cell Therapeutics and Milestone Scientific
ACCESSWIRE - Fri Dec 04, 7:30AM CST
NEW YORK, NY / ACCESSWIRE / December 4, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: HMN Financial Inc. (NASDAQ: HMNF), Metabolix Inc. (NASDAQ: MBLX), Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) and Milestone Scientific Inc. (NYSE: MLSS). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
HMNF: 14.79 (+0.43), MLSS: 2.18 (-0.17), BCLI: 2.39 (-0.04), MBLX: 0.41 (+0.01)
Metabolix Announces Third Quarter 2015 Financial Results
GlobeNewswire - Tue Nov 10, 3:05PM CST
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported financial results for the three months ended September 30, 2015.
MBLX: 0.41 (+0.01)
Renewable Chemicals Market 2015 - Alcohols, Biopolymers, Platform Chemicals & Others - Global Trends & Forecast to 2020
M2 - Tue Nov 10, 4:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/x84prd/renewable) has announced the addition of the "Renewable Chemicals Market - Alcohols (Ethanol, Methanol), Biopolymers (Starch Blends, Regenerated Cellulose, PBS, Bio-PET, PLA, PHA, Bio-PE, and Others), Platform Chemicals & Others - Global Trends & Forecast to 2020" report to their offering. The global renewable chemicals market is estimated to be USD 49.0 Billion in 2015 and is projected to reach USD 84.3 Billion by 2020, at a CAGR of 11.47% between 2015 and 2020. The renewable chemicals market is currently facing considerable competition from conventional chemicals derived from petrochemical feedstock; because the renewable chemicals market is susceptible to the volatility in crude oil prices, rising environmental concerns and governmental litigations. Market participants are witnessing the need to make a paradigm shift from petrochemical feedstock to renewable feedstock. This move would not only bring in economic benefits, it would also successfully address the rising concern over greenhouse gas emissions and their lasting impact on the environment. The threat of substitutes for renewable chemicals market is high. Presently, renewable chemicals account for a small share of the overall chemicals market. These renewable chemicals have higher prices when compared to the conventional chemicals. This ensures large availability of alternative chemicals for buyers and increases the chances of substitution. There are issues regarding the performance of some renewable chemicals which restricts its penetration in application markets. The increase in capacity utilization rate and new products launch are estimated to make the renewable chemicals market more competitive. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Renewable Chemicals Market, By Product Type 8 Renewable Chemicals Market, By Application 9 Regional Analysis 10 Catalysis & Technologies 11 Competitive Landscape 12 Company Profiles - BASF SE - Bioamber Inc. - Biome Technologies Plc - Biomethanol Chemie Nederland B.V. - Braskem - Cobalt Technologies Inc. - Corbion NV (Purac) - Dupont Tate & Lyle Bio Products Company, LLC - Genomatica Inc. - Metabolix Inc. - Mitsubishi Chemical Corp. - Myriant Corporation - Natureworks Llc - Reverdia For more information visit http://www.researchandmarkets.com/research/x84prd/renewable
MBLX: 0.41 (+0.01)
Metabolix to Present at Drexel Hamilton Conference
GlobeNewswire - Fri Oct 30, 8:15AM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that management will make a presentation to investors at the Drexel Hamilton Micro Cap Investor Forum on Thursday, November 12, 2015 at 9:00 a.m. ET.
MBLX: 0.41 (+0.01)
Metabolix to Conduct Webcast of Its Third Quarter 2015 Earnings Call
GlobeNewswire - Tue Oct 27, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it will be releasing its third quarter 2015 financial results after the market close on Tuesday, November 10, 2015. The full text of the earnings release also will be available on the Company's website at www.metabolix.com.
MBLX: 0.41 (+0.01)
Metabolix Signs Global, Exclusive Distribution Agreement With Kolar Filtration
GlobeNewswire - Thu Oct 15, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX) announced today that it has signed a global, exclusive distribution agreement with Kolar Filtration LLC for PHA-based denitrification pellets in water treatment applications including ornamental and hobby aquaria, ornamental ponds and fresh/salt water hatcheries and aqua farming. Under the agreement, Kolar will promote and market PHA-based denitrification pellets and will assume responsibility for servicing Metabolix's current roster of customers for DP9002 denitrification pellets.
MBLX: 0.41 (+0.01)
Metabolix, Inc. Announces $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
GlobeNewswire - Wed Oct 07, 3:05PM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced that it has entered into a $20 million common stock purchase agreement with Aspire Capital Fund, LLC. Under terms of the agreement, Aspire has committed to purchase up to $20 million of Metabolix's common stock over a 30 month period beginning on the effective date of the registration statement relating to the transaction. Common stock may be sold from time to time at the company's option under a pricing formula based on prevailing market prices around the time of each sale.
MBLX: 0.41 (+0.01)
Metabolix to Present New Findings on Multifunctional Benefits of PHA Biopolymers in PVC Applications
GlobeNewswire - Tue Oct 06, 8:00AM CDT
Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced that it will present its latest findings on the multifunctional benefits of bio-based PHA copolymers in a range of applications for polyvinyl chloride (PVC) and wood polymer composites. The new findings will be a key part of a technical presentation, entitled "Bio-based PHA Copolymers as Multifunctional Additives for Poly Vinyl Chloride Compound," to be delivered by Mansoor Akhthar, Metabolix application development manager - PVC, at the upcoming Vinyltec 2015 conference Oct.13-15 in Akron, Ohio.
MBLX: 0.41 (+0.01)
CORRECTING and REPLACING -- Metabolix Launches Yield10 Bioscience to Develop and Commercialize Innovations in Crop Science
GlobeNewswire - Thu Sep 17, 9:03AM CDT
In a release issued under the same headline earlier today by Metabolix, Inc. (NASDAQ:MBLX) please note that the link in the tenth paragraph of the release, should be "http://ir.metabolix.com/events.cfm" not "www.metabolix.com/events" as previously stated.
MBLX: 0.41 (+0.01)
(0)
(0)Scroll down for more posts ▼